Article
Clinical Actionability of Genes in Gastrointestinal Tumors
25 Sept 2025
Abstract excerpt
Precision oncology is witnessing an increasing number of molecular targets fueled by the continuous improvement of cancer genomics and drug development. Tumor genomic profiling is nowadays (August 2025) part of routine cancer patient care, guiding therapeutic decisions day by day. Nevertheless, implementing and distilling the increasing number of potential gene targets and possible precision drugs into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
